By Nate Raymond (Reuters) - Abbott Laboratories and AbbVie Inc will pay a total of $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for prescribing the cholesterol drug TriCor and promoted the medication for unapproved purposes.
from Latest News Business on Firstpost https://ift.tt/2CKuzEL
Sunday, 28 October 2018
Abbott, AbbVie settle TriCor marketing case for $25 million
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment